ASH Clinical News’ Editor-in-Chief and Associate Editors offer their perspective on current topics in hematology and healthcare.
The content of the Editor’s Corner is the opinion of the author and does not represent the official position of the American Society of Hematology unless so stated.
Have a comment about these editorials? Let us know what you think; we welcome your feedback. Email the editor at [email protected].
Making a Hematology Wishlist, and Checking it Twice
Thursday, December 29th, 2016 | January 2017, Volume 3, Issue 1 | Alice Ma, MD
Happy New Year! Can you believe it’s 2017 already? Another holiday season passed, another calendar page flipped, another year gone by. I thought that I was pretty good this year, earning a spot on the “nice” list, but Santa still didn’t leave all the presents I wanted under the tree. Here’s a sampling of gifts […]
So You Say You Want To Be A Clinical Researcher?
Tuesday, November 22nd, 2016 | December 2016, Volume 2, Issue 12 | Mikkael Sekeres, MD, MS
Perhaps you’ve just finished your hematology/oncology fellowship a year or two ago. Or you’re still a fellow and, having completed that intensive first year of inpatient consults and the speed dating outpatient rotations in different specialty clinics, you’ve just woken up to the realization that you have to apply for jobs in a year. Or […]
On Eating Bone Marrow
Thursday, October 27th, 2016 | November 2016, Volume 2, Issue 11 | David Steensma, MD
The first time I ate bone marrow was, fittingly, shortly after I spoke on marrow failure at a conference in Milan, where osso bucco with saffron risotto is a local specialty. The tiny, back-alley trattoria where I could afford dinner on a hematology fellow’s salary was praised in a guidebook written by public television’s European […]
A Primer on Email Etiquette
Monday, October 3rd, 2016 | October 2016, Volume 2, Issue 10 | Mikkael Sekeres, MD, MS
Every day, more than 200 billion emails are sent and received, for an average of 122 emails sent and received, per user, in a business setting.1 Having just returned from a week of vacation, we believe that approximately all of those 200 billion emails were waiting for us in our inboxes. As we spend increasing […]
The Decline and Fall of Cytotoxic Chemotherapy
Thursday, September 1st, 2016 | September 2016, Volume 2, Issue 9 | Keith Stewart, MBChB, MBA
Here, Dr. Stewart gives his take on whether cytotoxic chemotherapy should be declared a thing of the past. As ward rounds ended last Saturday, a slow-brew blend of my own clinical experience and what I have seen as reproducibly disappointing outcomes coalesced in my strong desire to speed the delivery of cytotoxic chemotherapy to the waste heap of […]